shareholdersunite.com

• The company has introduced a new product called Shield, which is complementary to their existing products and mostly meant for the commercial market where Intrusion hardly has any presence.
• They hired an experienced new CEO with numerous contacts in his rolodex, which will come in handy.
• The new product is in addition to the existing business, which reduces the risk, and even the existing business will likely benefit from the new CEO’s contacts.
• The new product Shield is a simple add-on to a company network and functions as a SaaS business, that alone should make the stock much more attractive.

Source: Intrusion’s New Product Could Be A Very Big Deal (OTCMKTS:INTZ) | Seeking Alpha

Sign up to receive premium content, fill out your email address on the top left (top choice) and receive early stock tips, before we publish these for the general public.

• The company has a dominant market share in marine scrubbing with its proprietary SiC filter technology, and growth seems assured due to new regulations.
• But the company has even larger market opportunities in the oil & gas industry and power plants, as well as a number of smaller segments.
• The company has four-folded production capacity, enjoys increasing gross margins and has lowered its break-even point as a result of cost cutting.
• The pandemic does have a negative impact, but this isn’t seen as lasting, the shares offer compelling value at these levels.

Source: LiqTech International Offers Compelling Value Here (NASDAQ:LIQT) | Seeking Alpha

• Slowly but surely, the company is cementing its position in the heart of the US healthcare sector, enabling participants to overcome some of the worst effects of its fragmentation.
• The pandemic has given its digital platform a shot in the arm, highlighting the importance of digital communication.
• The company seems to be strategically run with a firm eye of becoming an entrenched player, which it is well on the way of achieving.

Source: OptimizeRx Is Entrenching Its Position In Digital Healthcare Communication (NASDAQ:OPRX) | Seeking Alpha

• This year is going to be a disappointing year with ASP declines and a substantial decline in the market.
• While this is disappointing as management promised a robust year as little ago as March, they didn’t take their 2020 shipping guidance down.
• The Chinese market is likely to rebound towards the end of the year and the current shake out will favor Tier-1 producers like JinkoSolar in the end.

Source: JinkoSolar Is Likely To Rebound (NYSE:JKS) | Seeking Alpha

• The company merged with TiVo. Neither company has a solid growth history, and the combined net debt is substantial.
• Nevertheless, there are considerable revenue and cost synergy opportunities and pockets of growth in both.
• The company is also profitable and producing substantial amounts of cash flow, which makes the shares surprisingly cheap.

Source: Xperi’s Shares Are Surprisingly Cheap (NASDAQ:XPER) | Seeking Alpha

• At first sight, the massive shift from linear to CTV and the large Chinese market seem like a mega opportunity for CTV players like iQiyi.
• However, at present the company can’t even produce positive gross margins and is bleeding cash, despite solid subscriber and ARPU growth.
• And it turns out that much of the future operational leverage hoped for depends on government regulation controlling costs.

Source: We’ll Pass On iQiyi Shares, At Least For Now (NASDAQ:IQ) | Seeking Alpha

• The company is growing even faster than expected, and after substantial investment, it has reached profitability sooner.
• The runway seems pretty clear, based on superior tech and a large market need with the pandemic not hobbling progress.
• With operational leverage kicking in, the finances are set to improve substantially in the coming quarters.
• The easy money has been made from the March lows, but we still see considerable upside in the shares.

Source: RADA Electronic Industries Emerges Unscathed From The Pandemic (NASDAQ:RADA) | Seeking Alpha

• The company has simplified the testing of PAD, which is a marker for increased risk of stroke and cardiovascular disease.
• It runs on a capital light, license fee business model that generates high margins and substantial cash flows.
• The pandemic has interrupted the progress, but the company seems well placed to weather the storm.

Source: Semler Scientific: A Little Gem Of A Company (OTCMKTS:SMLR) | Seeking Alpha

• The company sprouts very capable and flexible card processing technology which has attracted a gilt-edged customer, enabling significant growth.
• However, the pandemic is slowing down that growth, although it remains to be seen by how much.
• Given the stellar margins, cash flow, balance sheet, and potential to land additional customers, we think that headwind has been priced into the shares already.

Source: Intelligent Systems: The Pandemic Headwind Is Already Priced In (NYSEMKT:INS) | Seeking Alpha

• The company’s strong growth is likely to suffer as a result of the pandemic, but we think this is only a temporary blip.
• The company rapidly adjusted and developed two COVID-19 tests for which demand is now ramping rapidly, and demand for their other tests will resume growth near term.
• The cost of rolling out the new tests and decline in their core business impacted results negatively, but this will be temporary as well.
• The end result is likely to be better as the costs are consumed, the COVID-19 tests ramp, and their existing business resurges.

Source: Fulgent’s COVID-19 Tests Are Ramping Fast, But Their Other Tests Are Suffering (NASDAQ:FLGT) | Seeking Alpha

• The company is marching on as if there is no pandemic, belying fears about the possible impact of soft device sales and a crash in the ad market.
• The company’s acquisition of Mobile Posse provides it with a recurring revenue stream, higher margins and plenty of revenue synergy opportunities to chase.
• Given the growth and cash flow profile, we think the shares are still surprisingly modestly valued.

Source: Digital Turbine Has More Room To Run (NASDAQ:APPS) | Seeking Alpha